查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1300988

北美脱髮市场规模、份额和趋势分析报告：按治疗（药物、设备）、按疾病类型（斑秃）、按最终用途、按销售渠道、按性别、按国家、按细分市场、2023 年预测～ 2030年

North America Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, Devices), By Disease Type (Alopecia Areata), By End-use, By Sales Channel, By Gender, By Country, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

北美脱髮市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，2023 年至 2030 年北美脱髮市场规模将以 7.5% 的复合年增长率增长，预计将达到56.5亿美元。

预计该市场将受到治疗技术进步和脱髮相关疾病患病率上升的共同推动。 此外，大公司的各种战略举措，例如光疗法和其他药物开发，预计也将在预测期内推动增长。

在北美脱髮行业，由于有影响力的市场进入者的存在，竞争对手之间的竞争预计将持续激烈。 品牌药的仿製药进一步加剧了商业竞争。 主要参与者参与针对临床需求未满足人群的新型治疗方法和药物的开发。 例如，Cassiopea S.p.A. 正在开发一种治疗女性男性型秃髮的药物。

国家斑秃基金会 (NAAF)、加拿大斑秃基金会和疤痕性秃髮研究基金会等组织支持治疗研究和开发以及产品开发。我们正在推动资助 例如，国家斑秃基金会 (NAAF) 为研究人员提供研究补助金和资金。 迄今为止，该组织已提供 208 项研究资助，总计约 570 万美元，用于支持疾病病理生理学、免疫途径和靶向治疗开发的研究。

此外，领先机构为缩小毛髮疾病研究差距而持续资助的计划可能会促进市场扩张。 例如，2021年4月，美国皮肤病学会宣布启动脱髮和脱髮研究倡议（HAIR）资助计划。 HAIR 计划为美国的研究人员、实习生和皮肤科医生提供资金，以完成研究项目，开发针对头髮疾病的新颖解决方案。

此外，监管部门的批准和主要参与者的各种战略举措预计将推动增长。 例如，2022年6月，Incyte和礼来公司宣布OLUMIANT（baricitinib）获得美国FDA批准用于成人严重AA的全身治疗。 Olmiant 有 1 毫克、2 毫克和 4 毫克片剂可供选择。 此外，2020 年 4 月，ITO Biosciences 宣布推出男性和女性非处方药米诺地尔。 该产品适用于脱髮恢復，可通过该公司的全资子公司 Innovus Pharmaceuticals 购买。

北美脱髮市场报告亮点

  • 就治疗剂而言，由于药品的广泛供应和新型治疗剂的存在，製药领域在北美脱髮行业中占有最大份额。
  • 由于对严重脱髮的认识提高，预计普秃将创下按疾病类型划分的最高复合年增长率
  • 从最终用途来看，激光技术等现代治疗方法的出现以及医生和皮肤科医生就诊次数的增加将使皮肤科诊所部门在 2022 年主导北美脱髮行业。
  • 到 2022 年，男性细分市场所占份额最大，而女性细分市场预计在预测期内将以最高复合年增长率增长。
  • 主要市场公司包括 Pfizer Inc、Eli Lilly and Company、Merck & Co., Inc、Concert Pharmaceuticals、Curallux, LLC、PureTech、Freedom Laser Therapy, Inc、LUTRONIC、HCW Biologics Inc、Curallux, LLC 等。是。

内容

第一章调查方法及范围

  • 市场细分和范围
    • 段定义
    • 细分市场和区域覆盖范围
    • 估计/预测时间表
  • 调查方法
  • 信息获取
    • 购买的数据库：
    • Gvr 内部数据库
    • 次要信息
    • 初步调查
    • 初步调查的详细信息
  • 信息或数据分析
    • 数据分析模型
  • 市场形成和验证
  • 型号详细信息
    • 产品流分析
  • 调查假设
  • 辅助信息列表
  • 缩写列表
  • 目的

第 2 章执行摘要

  • 市场概况
  • 片段快照
    • 竞争格局快照

第 3 章北美脱髮市场变量、趋势和范围

  • 市场体系展望
    • 母公司市场前景
    • 辅助市场展望
  • 绘製采用率和增长前景图
  • 监管状况
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
  • 脱髮：市场分析工具
    • 行业分析 - Porters -（药品）
    • 行业分析 - 搬运工（设备）
    • 按因素（政治/法律、经济/技术）进行 SWOT 分析（製药）
    • SWOT 分析，按要素（政治/法律、经济/技术）（设备）
  • 管道分析

第 4 章北美脱髮市场：2018-2030 年按疾病类型划分的细分市场分析（百万美元）

  • 北美脱髮市场：疾病类型变化分析
    • 2018-2030 年市场规模、预测、趋势分析
    • 斑秃
    • 疤痕性脱髮
    • 牵引性脱髮
    • 全秃
    • 普秃
    • 男性型秃髮
    • 其他

第 5 章北美脱髮市场：按治疗方式细分分析，2018-2030 年（百万美元）

  • 北美脱髮市场：治疗波动分析
  • 2018-2030年市场规模、预测及趋势分析
    • 药品
    • 设备

第 6 章北美脱髮市场：细分分析，性别，2018-2030 年（百万美元）

  • 北美脱髮市场：性别差异分析
  • 2018-2030 年市场规模、预测、趋势分析
    • 男性
    • 女性

第 7 章：北美脱髮市场：细分分析，按最终用途，2018-2030 年（百万美元）

  • 北美脱髮市场：最终用途变化分析
  • 2018-2030 年市场规模、预测、趋势分析
    • 家庭护理环境
    • 皮肤科诊所

第 8 章北美脱髮市场：2018-2030 年按地区划分的细分市场分析（百万美元）

  • 脱髮市场：按国家/地区划分的差异分析
  • 2022 年和 2030 年区域市场份额分析
  • 2018-2030 年市场规模、预测、收入和趋势分析
    • 北美

第9章北美脱髮市场：竞争分析（药品）

  • 主要市场进入者的最新趋势和影响分析
    • 推出新产品
    • 併购
    • 合资企业
    • 合作伙伴和许可协议
    • 会议和活动
  • 公司分类
    • 创新者
    • 市场领导者
    • 热图分析
  • 供应商情况
    • 主要分销商和渠道合作伙伴名单
    • 主要客户
  • 上市公司
    • 2022 年主要参与者的市场份额分析
    • 企业市场分析
    • 竞争仪表板分析
  • 私人公司
    • 主要初创企业名单
  • 公司简介（药品）
    • 西普拉有限公司
    • 太阳製药工业有限公司
    • 强生服务公司
    • 默克公司
    • 列剋星敦国际有限责任公司
    • Cirrus 头髮中心
    • VITA-COS-MED KLETT-LOCH GMBH
    • 过渡头髮
    • 纯科技健康
    • CURALLUX 有限责任公司
    • 雷迪博士实验室有限公司
    • 葛兰素史克 (GSK)
    • Aurobindo 製药公司
    • MYLAN NV（VIATRIS, INC.）

第10章北美脱髮市场：竞争分析（设备）

  • 主要市场进入者的最新趋势和影响分析
    • 主要交易和战略联盟分析
  • 公司分类
    • 创新者
    • 市场领导者
    • 热图分析
  • 供应商情况
    • 主要经销商和渠道合作伙伴名单
    • 主要客户
  • 上市公司
    • 竞争仪表板分析
    • 2022 年公司市场份额分析（设备）
  • 私人公司
    • 主要初创企业名单
  • 公司简介（设备）
    • FREEDOM LASER THERAPY, INC.
    • APIRA SCIENCE, INC.（IGROW LASER.）
    • REVIAN, INC
    • THERADOME INC.
    • LUTRONIC INC.
    • WON TECH CO., LTD
    • LIFEMD
    • LG ELECTRONICS
Product Code: GVR-4-68040-083-4

North America Alopecia Market Growth & Trends

The North America alopecia market size is expected to reach USD 5.65 billion by 2030, expanding at a 7.5% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to be collectively driven by technological advancements in treatments, and the rise in the prevalence of diseases associated with hair loss. Moreover, various strategic initiatives undertaken by leading players such as the development of light-based treatment and other pharmaceutical products developments are also anticipated to propel growth forward during the projected period.

The competitive rivalry in North America alopecia industry is likely to remain high due to the presence of prominent market participants. Generic copies of branded drugs further intensify commercial competition. Key players are involved in the development of novel therapies or drugs, to target people with unmet clinical needs. For instance, Cassiopea S.p.A. is engaged in the development of treatment for female androgenetic alopecia, as there is no drug approved for this particular indication.

Organizations, such as National Alopecia Areata Foundation (NAAF), Canadian Alopecia Areata Foundation, and Cicatricial Alopecia Research Foundation, among others, promote funding to support R&D and product development exercises pertaining to the treatment. For instance, National Alopecia Areata Foundation (NAAF) provides research grants and funding to researchers. To date, the organization has provided 208 research grants, totaling around USD 5.7 million, to sponsor studies on the pathophysiology of diseases, immune pathways, and developing targeted treatments.

Moreover, ongoing funding programs by leading organizations to decrease the gaps in hair disorders research is likely to expedite market expansion. For instance, in April 2021, the American Academy of Dermatology Association announced the launch of the Hair Loss and Alopecia Initiative in Research (HAIR) funding program. Under this HAIR program funding will be offered to researchers, trainees, and dermatologists in the U.S. for completing research projects for the development of novel solutions for hair disorders.

Furthermore, regulatory approvals and various strategic initiatives undertaken by leading players are expected to propel growth forward. For instance, in June 2022, Incyte and Eli Lilly and Company announced that OLUMIANT (baricitinib) received approval from the U.S. FDA for systemic treatment for adults with severe AA. OLUMIANT pill is available in 1 mg, 2 mg, and 4 mg tablets. In addition, in April 2020 Aytu BioScience, Inc. announced the launch of OTC foam formulation of minoxidil for men and women. This product is indicated for reversing hair loss and is available through the company's wholly-owned subsidiary Innovus Pharmaceuticals.

North America Alopecia Market Report Highlights

  • By treatment, the pharmaceutical segment held the largest share of the North America alopecia industry due to the widespread availability of pharmaceutical products, and the presence of novel therapeutics
  • The alopecia universalis segment is expected to register the highest CAGR rate in disease type segment owing to increasing awareness about severe forms of AA
  • By end-use, the dermatology clinics segment held the largest share of the North America alopecia industry in 2022 owing to the availability of modern treatment methods such as laser technology and increasing visits to doctors & dermatologists
  • The male gender segment held the largest share in 2022, whereas, the female gender segment is expected to register the highest CAGR rate during the forecast period
  • Some of the key market players include Pfizer Inc; Eli Lilly and Company; Merck & Co., Inc; Concert Pharmaceuticals; Curallux, LLC; PureTech; Freedom Laser Therapy, Inc; LUTRONIC; HCW Biologics Inc; Curallux, LLC; and others.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Definition
    • 1.1.2 Segment & Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
      • 2.3.Competitive Landscape Snapshot

Chapter 3 North America Alopecia Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration And Growth Prospect Mapping
  • 3.3 Regulatory Landscape
  • 3.4 Market Dynamics
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Increasing Prevalence Of Alopecia
      • 3.4.1.2 Increasing Healthcare Expenditure
      • 3.4.1.3 Increasing Prevalence Of Chronic Diseases
      • 3.4.1.4 Technological Advancements In Alopecia Treatment
    • 3.4.2 Market Restraint Analysis
      • 3.4.2.1 Lack Of Reimbursement Policies For Alopecia Treatment
      • 3.4.2.2 Increasing Adoption Of Substitutes
  • 3.5 Alopecia: Market Analysis Tools
    • 3.5.1 Industry Analysis - Porter's - (Pharmaceuticals)
    • 3.5.2 Industry Analysis - Porter's (Devices)
    • 3.5.3 Swot Analysis, By Factor (Political & Legal, Economic And Technological) (Pharmaceuticals)
    • 3.5.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological) (Devices)
  • 3.6 Pipeline Analysis

Chapter 4 North America Alopecia Market: Segment Analysis, By Disease Type, 2018 - 2030 (USD Million)

  • 4.1 North America Alopecia Market: Disease Type Movement Analysis
    • 4.1.1 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 4.1.2 Alopecia Areata
      • 4.1.2.1 Alopecia Areata Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.2.2 Male Alopecia Areata Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.2.3 Female Alopecia Areata Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.3 Cicatricial Alopecia
      • 4.1.3.1 Cicatricial Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.3.2 Male Cicatricial Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.3.3 Female Cicatricial Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.4 Traction Alopecia
      • 4.1.4.1 Traction Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.4.2 Male Traction Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.4.3 Female Traction Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.5 Alopecia Totalis
      • 4.1.5.1 List Of Organizations
      • 4.1.5.2 Alopecia Totalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.5.3 Male Alopecia Totalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.5.4 Female Alopecia Totalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.6 Alopecia Universalis
      • 4.1.6.1 Alopecia Universalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.6.2 Male Alopecia Universalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.6.3 Female Alopecia Universalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.7 Androgenetic Alopecia
      • 4.1.7.1 Androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.1.7.2 Male androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.1.7.3 Female androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.1.8 OTHERS
      • 4.1.8.1 Other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.1.8.2 Male other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.1.8.3 Female other alopecia market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 North America Alopecia Market: Segment Analysis, By Treatment, 2018 - 2030 (USD Million)

  • 5.1 North America Alopecia Market: Treatment Movement Analysis
  • 5.2 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.2.1 Pharmaceuticals
      • 5.2.1.1 Pharmaceuticals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2 Topical Drugs
      • 5.2.1.2.1 Topical Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.2 Topical Otc Drugs
      • 5.2.1.2.2.1 Topical Otc Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.2.2 Minoxidil
      • 5.2.1.2.2.2.1 Minoxidil Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.2.3 Other Otc Drugs
      • 5.2.1.2.2.3.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3 Topical Prescription Drugs
      • 5.2.1.2.3.1 Topical Prescription Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3.2 Betamethasone Dipropionate
      • 5.2.1.2.3.2.1 Betamethasone Dipropionate Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3.3 Fluocinolone Acetonide
      • 5.2.1.2.3.3.1 Fluocinolone Acetonide Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3.4 Finasteride
      • 5.2.1.2.3.4.1 Finasteride Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3.5 Minoxidil
      • 5.2.1.2.3.5.1 Minoxidil Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3 Oral Drugs
      • 5.2.1.3.1 Oral Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.2 Oral Otc Drugs
      • 5.2.1.3.2.1 Oral Otc Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.3 Oral Prescription Drugs
      • 5.2.1.3.3.1 Oral Prescription Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.3.2 Minoxidil
      • 5.2.1.3.3.2.1 Minoxidil Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.3.3 Finasteride
      • 5.2.1.3.3.3.1 Finasteride Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.3.4 Oral Corticosteroids
      • 5.2.1.3.3.4.1 Oral Corticosteroids Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.4 Platelet - Rich Plasma Injections
      • 5.2.1.4.1 Platelet - Rich Plasma Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2 Devices
      • 5.2.2.1 Devices Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.2 Laser Cap
      • 5.2.2.2.1 Laser Cap Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.3 Laser Comb
      • 5.2.2.3.1 Laser Comb Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.4 Laser Helmet
      • 5.2.2.4.1 Laser Helmet Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 North America Alopecia Market: Segment Analysis, By Gender, 2018 - 2030 (USD Million)

  • 6.1 North America Alopecia Market: Gender Movement Analysis
  • 6.2 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 6.2.1 Male
      • 6.2.1.1 Male Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Female
      • 6.2.2.1 Female Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 North America Alopecia Market: Segment Analysis, By End - Use, 2018 - 2030 (USD Million)

  • 7.1 North America Alopecia Market: End - Use Movement Analysis
  • 7.2 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 7.2.1 Homecare Settings
      • 7.2.1.1 Homecare Settings Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.2 Dermatology Clinics
      • 7.2.2.1 Dermatology Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 North America Alopecia Market: Segment Analysis, By Region, 2018 - 2030 (USD Million) (Number Of Patients, In Thousands)

  • 8.1 Alopecia Market: Country Movement Analysis
  • 8.2 Regional Market Share Analysis, 2022 & 2030
  • 8.3 Market Size, & Forecasts, Revenue And Trend Analysis, 2018 To 2030
    • 8.3.1 North America
      • 8.3.1.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.2 U.S.
      • 8.3.1.2.1 U.S. Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.3 Canada
      • 8.3.1.3.1 Canada Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 North America Alopecia Market: Competitive Analysis (Pharmaceuticals)

  • 9.1 Recent Developments And Impact Analysis, By Key Market Participants
    • 9.1.1 New Product Launches
    • 9.1.2 Mergers And Acquisitions
    • 9.1.3 Joint Venture
    • 9.1.4 Partnerships And Licensing Agreements
    • 9.1.5 Conferences And Campaigns
  • 9.2 Company Categorization
    • 9.2.1 Innovators
    • 9.2.2 Market Leaders
    • 9.2.3 Heat Map Analysis
  • 9.3 Vendor Landscape
    • 9.3.1 List Of Key Distributors And Channel Partners
    • 9.3.2 Key Customers
  • 9.4 Public Companies
    • 9.4.1 Key Company Market Share Analysis, 2022
    • 9.4.2 Company Market Position Analysis
    • 9.4.3 Competitive Dashboard Analysis
      • 9.4.3.1 Market Differentiators
  • 9.5 Private Companies
    • 9.5.1 List Of Key Emerging Companies
  • 9.6 Company Profiles (Pharmaceuticals)
    • 9.6.1 CIPLA LIMITED
      • 9.6.1.1 Company overview
      • 9.6.1.2 Financial Performance
      • 9.6.1.3 Product benchmarking
    • 9.6.2 SUN PHARMACEUTICALS INDUSTRIES LTD.
      • 9.6.2.1 Company overview
      • 9.6.2.2 Financial Performance
      • 9.6.2.3 Product benchmarking
      • 9.6.2.4 Strategic initiatives
    • 9.6.3 JOHNSON & JOHNSON SERVICES, INC.
      • 9.6.3.1 Company overview
      • 9.6.3.2 Financial Performance
      • 9.6.3.3 Product benchmarking
      • 9.6.3.4 Strategic initiatives
    • 9.6.4 MERCK & CO., INC.
      • 9.6.4.1 Company overview
      • 9.6.4.2 Financial Performance
      • 9.6.4.3 Product benchmarking
      • 9.6.4.4 Strategic initiatives
    • 9.6.5 LEXINGTON INTL., LLC
      • 9.6.5.1 Company overview
      • 9.6.5.2 Product benchmarking
    • 9.6.6 CIRRUS HAIR CENTERS
      • 9.6.6.1 Company overview
      • 9.6.6.2 Financial Performance
      • 9.6.6.3 Product benchmarking
    • 9.6.7 VITA - COS - MED KLETT - LOCH GMBH
      • 9.6.7.1 Company overview
      • 9.6.7.2 Product benchmarking
    • 9.6.8 TRANSITIONS HAIR
      • 9.6.8.1 Company overview
      • 9.6.8.2 Product benchmarking
    • 9.6.9 PURETECH HEALTH
      • 9.6.9.1 FOLLICA, INC.
      • 9.6.9.1.1 Company overview
      • 9.6.9.2 Financial Performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives
    • 9.6.10 CURALLUX, LLC
      • 9.6.10.1 Company overview
      • 9.6.10.2 Product benchmarking
      • 9.6.10.3 Strategic initiatives
    • 9.6.11 DR. REDDY'S LABORATORIES LTD
      • 9.6.11.1 Company overview
      • 9.6.11.2 Financial Performance
      • 9.6.11.3 Product benchmarking
      • 9.6.11.4 Strategic initiatives
    • 9.6.12 GLAXOSMITHKLINE PLC (GSK)
      • 9.6.12.1 Company overview
      • 9.6.12.2 Financial Performance
      • 9.6.12.3 Product benchmarking
    • 9.6.13 AUROBINDO PHARMA
      • 9.6.13.1 Company overview
      • 9.6.13.2 Financial Performance
      • 9.6.13.3 Product benchmarking
    • 9.6.14 MYLAN N.V. (VIATRIS, INC.)
      • 9.6.14.1 Company overview
      • 9.6.14.2 Financial Performance
      • 9.6.14.3 Product benchmarking
      • 9.6.14.4 Strategic initiatives

Chapter 10 North America Alopecia Market: Competitive Analysis (Devices)

  • 10.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 10.1.1 Major Deals And Strategic Alliances Analysis
      • 10.1.1.1 New Product Launches
      • 10.1.1.2 Partnerships and Licensing Agreements
      • 10.1.1.3 Conferences and Campaigns
  • 10.2 Company Categorization
    • 10.2.1 Innovators
    • 10.2.2 Market Leaders
    • 10.2.3 Heat Map Analysis
  • 10.3 Vendor Landscape
    • 10.3.1 List Of Key Distributors And Channel Partners
    • 10.3.2 Key Customers
  • 10.4 Public Companies
    • 10.4.1 Competitive Dashboard Analysis
      • 10.4.1.1 Market Differentiators
    • 10.4.2 Company Market Share Analysis (Devices), 2022
  • 10.5 Private Companies
    • 10.5.1 List Of Key Emerging Companies
  • 10.6 Company Profiles (Devices)
    • 10.6.1 FREEDOM LASER THERAPY, INC.
      • 10.6.1.1 Company overview
      • 10.6.1.2 Product benchmarking
      • 10.6.1.3 Strategic initiatives
    • 10.6.2 APIRA SCIENCE, INC. (IGROW LASER.)
      • 10.6.2.1 Company overview
      • 10.6.2.2 Product benchmarking
      • 10.6.2.3 Strategic initiatives
    • 10.6.3 REVIAN, INC
      • 10.6.3.1 Company overview
      • 10.6.3.2 Product benchmarking
      • 10.6.3.3 Strategic initiatives
    • 10.6.4 THERADOME INC.
      • 10.6.4.1 Company overview
      • 10.6.4.2 Product benchmarking
      • 10.6.4.3 Strategic initiatives
    • 10.6.5 LUTRONIC INC.
      • 10.6.5.1 Company overview
      • 10.6.5.2 Product benchmarking
      • 10.6.5.3 Strategic initiatives
    • 10.6.6 WON TECH CO., LTD
      • 10.6.6.1 Company overview
      • 10.6.6.2 Product benchmarking
      • 10.6.6.3 Strategic initiatives
    • 10.6.7 LIFEMD
      • 10.6.7.1 Company overview
      • 10.6.7.2 Product benchmarking
      • 10.6.7.3 Strategic initiatives
    • 10.6.8 LG ELECTRONICS
      • 10.6.8.1 Company overview
      • 10.6.8.2 Product benchmarking
      • 10.6.8.3 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Regulatory framework
  • Table 4 List of late-stage clinical trials
  • Table 5 Approved generic version of Avodart:
  • Table 6 Androgenetic alopecia in men and women
  • Table 7 List of parameters
  • Table 8 Leading market players anticipated to witness highest growth
  • Table 9 List of key distributors
  • Table 10 Key company market share (%)
  • Table 11 List of parameters
  • Table 12 Leading market players anticipated to witness highest growth
  • Table 13 List of other distributors
  • Table 14 Key company market share (%)
  • Table 15 North America Alopecia Market, By Country, 2018 - 2030 (USD Million)
  • Table 16 North America Alopecia Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 17 North America Alopecia Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 18 North America Alopecia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 19 North America Alopecia Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 20 North America Alopecia Market, By Gender, 2018 - 2030 (USD Million)
  • Table 21 U.S. Alopecia Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 22 U.S. Alopecia Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 23 U.S. Alopecia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 24 U.S. Alopecia Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 25 U.S. Alopecia Market, By Gender, 2018 - 2030 (USD Million)
  • Table 26 Canada Alopecia Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 27 Canada Alopecia Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 28 Canada Alopecia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 29 Canada Alopecia Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 30 Canada Alopecia Market, By Gender, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 North America alopecia market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Primary interviews, by type
  • Fig. 6 Primary interviews, by country
  • Fig. 7 Market research approaches
  • Fig. 8 Value - chain - based sizing & forecasting
  • Fig. 9 QFD modeling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Market outlook (2022)
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Porter's five forces analysis, Devices
  • Fig. 17 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 18 SWOT analysis, by factor (political & legal, economic, and technological), Devices
  • Fig. 19 North America alopecia market disease type outlook: Key takeaways
  • Fig. 20 North America alopecia market: Disease type movement analysis
  • Fig. 21 Alopecia areata market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Male alopecia areata market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Female alopecia areata market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Cicatricial alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Male cicatricial alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Female cicatricial alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Traction alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Male traction alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Female traction alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Alopecia totalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Male alopecia totalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Female alopecia totalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Alopecia universalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Male alopecia universalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Female alopecia universalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Male androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Female androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Male other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Female other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 North America Alopecia market treatment outlook: Key Takeaways
  • Fig. 43 Alopecia market: Treatment movement analysis
  • Fig. 44 Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Topical drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Topical OTC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Minoxidil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Topical prescription drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Betamethasone dipropionate market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Fluocinolone acetonide market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Finasteride market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Minoxidil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Oral drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Oral OTC drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Oral prescription drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Minoxidil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Finasteride market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Oral corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Platelet - rich plasma market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Laser cap market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Laser comb market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Laser helmet market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 North America Alopecia market gender outlook: Key takeaways
  • Fig. 66 North America Alopecia market: Gender movement analysis
  • Fig. 67 Male market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Female market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 North America Alopecia market end - use outlook: Key takeaways
  • Fig. 70 North America Alopecia market: end - use movement analysis
  • Fig. 71 Homecare settings market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Dermatology clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 North America Alopecia market sales channel outlook: Key takeaways
  • Fig. 74 North America Alopecia market: Sales channel movement analysis
  • Fig. 75 Prescriptions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 OTC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Regional outlook, 2022 & 2030
  • Fig. 78 North America
  • Fig. 79 North America alopecia market estimates and forecast, 2018 - 2030 (USD Million) (Number of Patients, in Thousands)
  • Fig. 80 U.S.
  • Fig. 81 U.S. alopecia market estimates and forecast, 2018 - 2030 (USD Million) (Number of Patients, in Thousands)
  • Fig. 82 Canada
  • Fig. 83 Canada alopecia market estimates and forecast, 2018 - 2030 (USD Million) (Number of Patients, in Thousands)
  • Fig. 84 Heat map analysis
  • Fig. 85 Company market position analysis (2022)
  • Fig. 86 Company market position analysis (2022)
  • Fig. 87 Market differentiators
  • Fig. 88 Strategy mapping
  • Fig. 89 Heat map analysis
  • Fig. 90 Market differentiators